News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vivalis, GlaxoSmithKline (GSK) Win OK For First Human Trial With EB66


11/24/2010 8:07:20 AM

PARIS Nov 24 (Reuters) - French biotech Vivalis (VLS.PA) and its British partner GlaxoSmithKline (GSK.L) have won U.S. clearance to begin testing for the first time on humans flu vaccines that were produced using Vivalis's technology.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES